Smith & Nephew plc (NYSE:SNN) Shares Sold by Bank of Montreal Can

Bank of Montreal Can trimmed its holdings in shares of Smith & Nephew plc (NYSE:SNN - Free Report) by 71.5% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 351,982 shares of the medical equipment provider's stock after selling 883,934 shares during the period. Bank of Montreal Can owned about 0.08% of Smith & Nephew worth $10,954,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of SNN. Mather Group LLC. increased its stake in shares of Smith & Nephew by 9,735.3% during the 2nd quarter. Mather Group LLC. now owns 1,672 shares of the medical equipment provider's stock worth $42,000 after purchasing an additional 1,655 shares in the last quarter. Allspring Global Investments Holdings LLC increased its stake in shares of Smith & Nephew by 1,894.3% during the 2nd quarter. Allspring Global Investments Holdings LLC now owns 1,735 shares of the medical equipment provider's stock worth $43,000 after purchasing an additional 1,648 shares in the last quarter. EverSource Wealth Advisors LLC increased its stake in shares of Smith & Nephew by 92.5% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 2,454 shares of the medical equipment provider's stock worth $61,000 after purchasing an additional 1,179 shares in the last quarter. GAMMA Investing LLC increased its stake in shares of Smith & Nephew by 160.0% during the 3rd quarter. GAMMA Investing LLC now owns 2,257 shares of the medical equipment provider's stock worth $70,000 after purchasing an additional 1,389 shares in the last quarter. Finally, Opal Wealth Advisors LLC purchased a new stake in Smith & Nephew in the 2nd quarter worth approximately $101,000. 25.64% of the stock is owned by hedge funds and other institutional investors.

Smith & Nephew Stock Down 0.0 %

Smith & Nephew stock traded down $0.01 during trading on Monday, reaching $25.77. 219,203 shares of the company's stock were exchanged, compared to its average volume of 867,619. The company has a quick ratio of 1.11, a current ratio of 2.51 and a debt-to-equity ratio of 0.63. The company's 50-day moving average is $27.58 and its two-hundred day moving average is $27.90. Smith & Nephew plc has a 52-week low of $23.65 and a 52-week high of $31.72.

Wall Street Analysts Forecast Growth

Several analysts have commented on SNN shares. Berenberg Bank cut shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Wednesday, November 6th. StockNews.com cut shares of Smith & Nephew from a "strong-buy" rating to a "buy" rating in a research note on Tuesday, November 12th. Finally, Deutsche Bank Aktiengesellschaft cut shares of Smith & Nephew from a "buy" rating to a "hold" rating in a research note on Friday, November 1st.

Smith & Nephew Company Profile

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.